This statistic shows the value of select EU and U.S. biotech companies initial public offerings (IPOs) as reported between January and October 2017. According to the report, Biohaven Pharmaceutical Holding Company had a IPO valued at 193.5 million U.S. dollars.
Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017
(in million U.S. dollars)
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
EY, & S&P Capital IQ. (November 30, 2017). Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 27, 2020, from https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY, und S&P Capital IQ. "Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)." Chart. November 30, 2017. Statista. Accessed May 27, 2020. https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY, S&P Capital IQ. (2017). Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 27, 2020. https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY, and S&P Capital IQ. "Value of U.S. and European Biotech Initial Public Offerings (Ipos) in January-october 2017 (in Million U.S. Dollars)." Statista, Statista Inc., 30 Nov 2017, https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY & S&P Capital IQ, Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars) Statista, https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/ (last visited May 27, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
